» Articles » PMID: 9647355

In Vitro Dissolution Profile Comparison--statistics and Analysis of the Similarity Factor, F2

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 1998 Jul 1
PMID 9647355
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To describe the properties of the similarity factor (f2) as a measure for assessing the similarity of two dissolution profiles. Discuss the statistical properties of the estimate based on sample means.

Methods: The f2 metrics and the decision rule is evaluated using examples of dissolution profiles. The confidence interval is calculated using bootstrapping method. The bias of the estimate using sample mean dissolution is evaluated.

Results: 1. f2 values were found to be sensitive to number of sample points, after the dissolution plateau has been reached. 2. The statistical evaluation of f2 could be made using 90% confidence interval approach. 3. The statistical distribution of f2 metrics could be simulated using 'Bootstrap' method. A relatively robust distribution could be obtained after more than 500 'Bootstraps'. 4. A statistical 'bias correction' was found to reduce the bias.

Conclusions: The similarity factor f2 is a simple measure for the comparison of two dissolution profiles. But the commonly used similarity factor estimate f2 is a biased and conservative estimate of f2. The bootstrap approach is a useful tool to simulate the confidence interval.

Citing Articles

RSM and AI based machine learning for quality by design development of rivaroxaban push-pull osmotic tablets and its PBPK modeling.

Saleem M, Shoaib M, Yousuf R, Siddiqui F Sci Rep. 2025; 15(1):7922.

PMID: 40050302 PMC: 11885842. DOI: 10.1038/s41598-025-91601-z.


A Perspective on the Use of Hydroxyapatites to Improve the Dissolution Behavior of Poorly Water-Soluble Piretanide.

Friuli V, Loi C, Bruni G, Maggi L, Bini M Pharmaceutics. 2024; 16(11).

PMID: 39598573 PMC: 11597431. DOI: 10.3390/pharmaceutics16111450.


Screening of Polymers for Oral Ritonavir Amorphous Solid Dispersions by Film Casting.

Oktay A, Polli J Pharmaceutics. 2024; 16(11).

PMID: 39598497 PMC: 11597764. DOI: 10.3390/pharmaceutics16111373.


Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets.

Park S, Choi S Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598435 PMC: 11597698. DOI: 10.3390/ph17111525.


Chemical Distribution Uniformity Assessment of "Intra-Tablet" by Hyperspectral Raman Imaging Analysis.

Sun N, Zhang J, Guo M, Mao Y, Wu W, Lu Y Pharm Res. 2024; 41(11):2247-2258.

PMID: 39505780 DOI: 10.1007/s11095-024-03778-z.


References
1.
Shah V, Yamamoto L, Schuirman D, Elkins J, Skelly J . Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets. Pharm Res. 1987; 4(5):416-9. DOI: 10.1023/a:1016442514205. View

2.
Sathe P, Tsong Y, Shah V . In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res. 1996; 13(12):1799-803. DOI: 10.1023/a:1016020822093. View

3.
Polli J, Rekhi G, Augsburger L, Shah V . Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J Pharm Sci. 1997; 86(6):690-700. DOI: 10.1021/js960473x. View

4.
Chow S, Ki F . Statistical comparison between dissolution profiles of drug products. J Biopharm Stat. 1997; 7(2):241-58. DOI: 10.1080/10543409708835184. View

5.
MALINOWSKI H, Marroum P, Uppoor V, Gillespie W, Ahn H, Lockwood P . Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations. Adv Exp Med Biol. 1997; 423:269-88. DOI: 10.1007/978-1-4684-6036-0_25. View